OLIVER CHIU: Open Payments
NPI 1740725068 · WEST COVINA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 19 payments from 9 companies in 2025. Trend: 2023 $617 · 2024 $964 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $253 |
| Novo Nordisk Inc | 5 | $92 |
| Sumitomo Pharma America, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Kerendia, Ozempic, Rybelsus, GEMTESA, FARXIGA, VOQUEZNA, MOUNJARO, JARDIANCE.
Industry payments across CA — which companies pay providers there.
